Publications | Lund University Publications

11 – 20 of 28

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=keywords+exact+%22Drug+Design%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2015
Mark Assessment of Computational Methods for Ligand Binding
Mikulskis, Paulius ^LU (2015)
- Thesis › Doctoral thesis (compilation)
Mark Virtual screening for identifying a putative inhibitor of rmlc, a major target protein in tuberculosis disease
Shefin, B. and Sunilkumar, Bindu A. ^LU (2015) In International Journal of Pharma and Bio Sciences 6(4). p.616-628
- Contribution to journal › Article
Mark Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design
Fjellström, Ola ; Akkaya, Sibel ; Beisel, Hans-Georg ; Eriksson, Per-Olof ; Erixon, Karl ; Gustafsson, David ; Jurva, Ulrik ; Kang, Daiwu ; Karis, David and Knecht, Wolfgang ^LU , et al. (2015) In PLoS ONE 10(1).
- Contribution to journal › Article
Mark Compstatin : a C3-targeted complement inhibitor reaching its prime for bedside intervention
Mastellos, Dimitrios C ; Yancopoulou, Despina ; Kokkinos, Petros ; Huber-Lang, Markus ; Hajishengallis, George ; Biglarnia, Ali R ^LU ; Lupu, Florea ; Nilsson, Bo ; Risitano, Antonio M and Ricklin, Daniel , et al. (2015) In European Journal of Clinical Investigation 45(4). p.40-423
- Contribution to journal › Scientific review
2014
Mark Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors
Liscio, Paride ; Carotti, Andrea ; Asciutti, Stefania ; Karlberg, Tobias ^LU ; Bellocchi, Daniele ; Llacuna, Laura ; Macchiarulo, Antonio ; Aaronson, Stuart A ; Schüler, Herwig ^LU and Pellicciari, Roberto , et al. (2014) In Journal of Medicinal Chemistry 57(6). p.12-2807
- Contribution to journal › Article
2013
Mark Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules : comparison with (111)In-labeled counterparts
Strand, Joanna ^LU ; Honarvar, Hadis ; Perols, Anna ; Orlova, Anna ; Selvaraju, Ram Kumar ; Karlström, Amelie Eriksson and Tolmachev, Vladimir (2013) In PLoS ONE 8(8).
- Contribution to journal › Article
2012
Mark On the estimation of ligand binding affinities
Genheden, Samuel ^LU (2012)
- Thesis › Doctoral thesis (compilation)
Mark Inhibition mechanism of human galectin-7 by a novel galactose- benzylphosphate inhibitor
Masuyer, Geoffrey ; Jabeen, Talat ; Öberg, Christopher T. ^LU ; Leffler, Hakon ^LU ; Nilsson, Ulf J. ^LU and Acharya, K. Ravi (2012) In The FEBS Journal 279(2). p.193-202
- Contribution to journal › Article
Mark Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents
Olmstead, Andrea D ; Knecht, Wolfgang ^LU ; Lazarov, Ina ; Dixit, Surjit B and Jean, François (2012) In PLoS Pathogens 8(1).
- Contribution to journal › Article
Mark Influence of DOTA chelator position on biodistribution and targeting properties of (111)In-labeled synthetic anti-HER2 affibody molecules
Perols, Anna ; Honarvar, Hadis ; Strand, Joanna ^LU ; Selvaraju, Ramkumar ; Orlova, Anna ; Karlström, Amelie Eriksson and Tolmachev, Vladimir (2012) In Bioconjugate Chemistry 23(8). p.70-1661
- Contribution to journal › Article

your query:: Remove keywords: Drug Design